Showing results (141-150 of 322) with videos related to
Sort By:
Pageof 33
Biotherapy (Dordrecht, Netherlands)|February 9, 1999
Low dose oral interferon alpha 2a in HIV-1 seropositive patients: a double-blind, placebo-controlled trialS E Wright, D P Hutcheson, J M CumminsBiotherapy (Dordrecht, Netherlands)|January 1, 1990
Successful adoptive immunotherapy with OK432-inducible activated natural killer cells in tumor-bearing miceH Yamaue, H Tanimura, M Iwahashi, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Serodiagnosis of cancer, using porcine antigens recognized by human monoclonal antibody, HB4C5S Hashizume, K Mochizuki, H Murakami, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Unusual antiproliferative effects of transforming growth factors-beta 1 and beta 2 against primary cells from human tumorsA M Daniels, J M McPherson, J R Daniels, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytomaN Kan, T Okino, M Nakanishi, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Effector mechanism of human monocyte-mediated cytotoxicity: role of a new tumor cytotoxic factor distinct from interleukin 1 and tumor necrosis factor alphaS Sone, M Munekata, M Tanaka, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
The "double grafted tumor system", proposed to find effector cells in the analyses of antitumor effect of BRMsH Kohya, T Ebina, T Yamaguchi, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1991
Chimeric antibody: potential applications for drug delivery and immunotherapyS U ShinBiotherapy (Dordrecht, Netherlands)|January 1, 1991
Clinical experience of targeted therapyH G EichlerBiotherapy (Dordrecht, Netherlands)|January 1, 1989
Leucoagglutinin induces differential proliferation of lymphocyte subsetsS P Goedegebuure, R J van de Griend, C P Ronteltap, et al.Pageof 33